NCT00634673
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia, +7 more
- Locations
-
- Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
948 public trials
78 recruiting studies
Dyslipidemias trial results
NCT00005760
- Conditions
- Body Weight, Cardiovascular Diseases, Diabetes Mellitus, +22 more
- Locations
-
- National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States
Completed
Leptin to Treat Lipodystrophy
NCT00005905
- Conditions
- Diabetes Mellitus, Digestive System Diseases, Dyslipidemias, +14 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
Completed
Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins
NCT00001226
- Conditions
- Dyslipidemias, Healthy, Hyperlipidemias, +5 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
NCT00625170
- Conditions
- Dyslipidemia, Dyslipidemias, Glucose Metabolism Disorders, +5 more
- Locations
-
- Leiden University Medical Center Leiden, Netherlands
NCT00605787
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia, +7 more
- Locations
-
- Haukeland University Hospital Bergen, Norway
NCT00350038
- Conditions
- Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
- Sanofi-aventis Budapest, Hungary
NCT00287404
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +7 more
- Locations
-
- University of North Carolina Diabetes Care Center Durham, North Carolina, United States
NCT00405197
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemia, +16 more
- Locations
-
- Hospital Gelderse Vallei Ede, Netherlands
- Wageningen University, Division of Human Nutrition Wageningen, Netherlands
NCT00267254
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +5 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Mesa, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States